Calyxo
An innovation-driven medical device company focused on improving care for patients with kidney stones, a common and painful condition that consumes vast amounts of healthcare resources today.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor | €0.0 | round | |
* | $50.0m | Series D | |
| Total Funding | 000k | ||
Related Content
Calyxo, Inc. specializes in developing cutting-edge medical devices aimed at revolutionizing the treatment of kidney stones. Founded in February 2016 in collaboration with leading U.S. urologists, the company addresses the significant clinical needs in the field of urology. Calyxo's core mission is to improve patient care by providing innovative solutions that enable urologists to achieve superior clinical outcomes safely and efficiently. The company operates in the medical device market, specifically targeting healthcare providers and urology specialists. Its business model revolves around the development, commercialization, and sale of advanced medical devices designed to treat kidney stones more effectively. Revenue is generated through the sale of these devices to hospitals, clinics, and medical professionals. The leadership team at Calyxo brings extensive experience in medical device startups, product development, and commercial launch, ensuring a strong foundation for the company's growth and success.
Keywords: kidney stones, urology, medical devices, innovation, clinical outcomes, healthcare, patient care, commercialization, product development, startups.